Pyrrolopyrimidine compounds and their uses
US8415355B2 · kind B2 · utility
29Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 21, 2009 |
| Grant date | Apr 9, 2013 |
| Priority date | — |
| Expiry date | Jan 26, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) and to pharmaceutically acceptable salts and pharmaceutical compositions thereof. The present invention also relates to use of the compounds of formula (I) in modulating the activity of protein kinases and in the treatment of disease, particularly a disease, disorder or syndrome associated with CDK 4 inhibition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.